Lumos Diagnostics

Activity by year

202120222023202420252026

ContractNew facility

Jul 16, 2025CONTRACTUnited States$2.00M
Lumos Diagnostics signs exclusive U.S. distribution deal with PHASE Scientific for FebriDx
Lumos Diagnostics has signed a six-year exclusive U.S. distribution agreement with PHASE Scientific for FebriDx, with $2.0 million upfront and potential total contract value of up to $317 million.
Lumos Diagnostics PHASE Scientific customer #Medical Devices lumosdiagnostics.com
Feb 3, 2022NEW FACILITYMelbourne, Victoria, Australia70 jobsops Apr 2022
Planet Innovation and Lumos Diagnostics to open rapid antigen test facility in Melbourne
Planet Innovation and Lumos Diagnostics will open a new Covid-19 rapid antigen test production facility at PI's Melbourne factory, with full capacity of 50 million tests per year. The facility is expected to create 70 full-time jobs.
Planet Innovation Lumos Diagnostics partner #Medical Devices aumanufacturing.com.au
Dec 20, 2021CONTRACTCanada$250K
Lumos Diagnostics receives initial orders for CoviDx in Canada
Lumos Diagnostics received initial orders worth approximately US$250,000 for its CoviDx SARS-CoV-2 rapid antigen test in Canada, expected to ship in December 2021.
Lumos Diagnostics #Medical Devices listcorp.com

Customers

Loading…